Symptomatic Improvement and Enhanced Quality of Life in Individuals with Atherosclerotic Cardiovascular Disease Following a 12-Week Self-Monitored Regimen of Rectally Administered 2-Hydroxypropyl-β-Cyclodextrin (Cavadex): An Observational Study
By Kyle Hodgetts · 2025 · Read by 1396 — Symptomatic Improvement and Enhanced Quality of Life in Individuals with Atherosclerotic Cardiovascular Disease Following a 12-Week Self-Monitored Regimen of Rectally Administered 2-Hydroxypropyl-β-Cyclodextrin (Cavadex): An Observational Study in Cardiology Research and Cardiovascular Medicine
Publication Details
- Journal
- Cardiology Research and Cardiovascular Medicine
- Published
- 2025-09-24
- DOI
- https://doi.org/10.29011/2575-7083.100287
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00